25 filings
8-K
FWBI
First Wave BioPharma Inc
30 Dec 19
Entry into a Material Definitive Agreement
5:09pm
8-K
FWBI
First Wave BioPharma Inc
20 Dec 19
Departure of Directors or Certain Officers
3:39pm
8-K
FWBI
First Wave BioPharma Inc
14 Nov 19
AzurRx BioPharma, Inc. Announces Equity Purchase Agreement
9:00am
8-K
FWBI
First Wave BioPharma Inc
1 Nov 19
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:30pm
8-K
FWBI
First Wave BioPharma Inc
22 Oct 19
AzurRx BioPharma CEO Issues Letter to Shareholders
3:30pm
8-K
d0s0zjzboq
17 Oct 19
AzurRx BioPharma Announces Positive CFF DSMB Review of Final Phase 2 OPTION Trial Data
2:04pm
8-K
hu2rcwmwz
15 Oct 19
Regulation FD Disclosure
8:31am
8-K
eeb2unuul8dhx ip4do
15 Oct 19
Other Events
8:30am
8-K
zl8ple yiau6d8va
11 Oct 19
AzurRx BioPharma Announces Appointment of James
5:15pm
8-K
hjwkn5avhw
9 Oct 19
Regulation FD Disclosure
6:03am
8-K
gkspk5l
25 Sep 19
AzurRx BioPharma Announces Positive Results from Phase 2 Trial with MS1819 in Cystic Fibrosis Patients
5:25pm
8-K
8or8k38e1fvqm76dty
22 Jul 19
Entry into a Material Definitive Agreement
5:28pm
8-K
3p090
10 Jul 19
Regulation FD Disclosure
2:36pm
8-K
zlpq9eirjonos1y
9 Jul 19
Regulation FD Disclosure
12:00am
8-K
759g758b8tj6vssau
7 Jun 19
Other Events
5:00pm
8-K
qp7dws2lsp p1
6 Jun 19
Regulation FD Disclosure
12:00am
8-K
1fssfwd5w 06adc3pmko
23 May 19
Other Events
5:01pm
8-K
959wm
20 May 19
Statistical significance achieved on multiple secondary endpoints
5:00pm
8-K
b0dyc8uia bjkp
14 May 19
Entry into a Material Definitive Agreement
4:05pm
8-K
q1i1ewtk
7 May 19
Regulation FD Disclosure
1:03pm